ALX1-11: Began Phase I trial

Allelix Biopharmaceuticals Inc. (TSE:AXB), Toronto Product: ALX1-11, parathyroid hormone Indication: Osteoporosis Status: Began a two-arm European Phase I trial of the drug, which is being co-develo...